Relations of clinical features, subgroups and medication to serum monoamines in schizophrenia-Reference-Cited by-同舟云学术

Relations of clinical features, subgroups and medication to serum monoamines in schizophrenia

Published:2002-01 Issue:1 Volume:17 Page:15-27
ISSN:0885-6222
Container-title:Human Psychopharmacology: Clinical and Experimental
language:en
Short-container-title:Hum. Psychopharmacol. Clin. Exp.

Author:

Oades Robert D.,Klimke Ansgard,Henning Uwe,Rao Marie Luise

Publisher

Wiley

Subject

Pharmacology (medical),Psychiatry and Mental health,Clinical Neurology,Neurology

Reference77 articles.

1. Relationships between clinical effects and monoamine metabolites and amino acids in sulpiride-treated schizophrenic patients

2. American Psychiatric Association. 1994. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), 4th edn. American Psychiatric Association: Washington, DC.

3. Assessment of the Central Dopaminergic Index of Plasma HVA in Schizophrenia

4. Negative v Positive Schizophrenia

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Associations between five-factor model of the Positive and Negative Syndrome Scale and plasma levels of monoamine metabolite in patients with schizophrenia;Psychiatry Research;2015-12

2. Relationship between Plasma Homovanillic Acid and Outcome in Patients with Psychosis Spectrum Disorders;Neuropsychobiology;2015

3. Long-term consequences of adolescent cannabinoid exposure in adult psychopathology;Frontiers in Neuroscience;2014-11-10

4. Abnormal plasma monoamine metabolism in schizophrenia and its correlation with clinical responses to risperidone treatment;Psychiatry Research;2011-07

5. Plasma homovanillic acid differences in clinical subgroups of first episode schizophrenic patients;Psychiatry Research;2009-07